• Aucun résultat trouvé

Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry

N/A
N/A
Protected

Academic year: 2021

Partager "Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry"

Copied!
8
0
0

Texte intégral

(1)

HAL Id: hal-01788817

https://hal.umontpellier.fr/hal-01788817

Submitted on 6 May 2020

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French

Pulmonary Hypertension Registry

David Montani, Julien Henry, Caroline O’Connell, Xavier Jaïs, Vincent Cottin, David Launay, Gilbert Habib, Arnaud Bourdin, Mitja Jevnikar,

Laurent Savale, et al.

To cite this version:

David Montani, Julien Henry, Caroline O’Connell, Xavier Jaïs, Vincent Cottin, et al.. Associa- tion between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension Registry. Respiration, Karger, 2018, 95 (4), pp.244 - 250. �10.1159/000485631�. �hal- 01788817�

(2)
(3)
(4)
(5)
(6)
(7)
(8)

Références

Documents relatifs

In patients with PH due to res- piratory disease, the percentages of responders ac- cording to the treating physician seemed larger, whereas the percentage of acute responder

The objective of this study is to investigate the ability and accuracy of OCT to detect and quantify intimal fibrosis, as a marker of histological remodeling of the pulmonary

During the vascular remodeling process in PAH subjects, Ang-1 was significantly decreased in the pulmonary arteries along with a reduction of Tie-2, a novel

Paediatric patients from age 0–18 years with the di- agnosis of pulmonary arterial hypertension of all aetiolo- gies except persistent pulmonary hypertension of the newborn

Rapamycin given in vivo to rats therefore inhibited the mTOR signaling pathway in a manner very similar to that seen with direct cell exposure, inhibiting both mTORC1

has received payment for lectures from Actelion. has received payment for consultancy and lectures from Actelion, Bayer, BMS, GlaxoSmithKline, MSD, and Pfizer. His institution

Thiene et al demonstrated that lung segments perfused by large, nonstenotic systemic collateral arteries in patients with pulmonary atresia had features of proliferative

Pulmonary hypertension is defined as an invasive pul- monary artery mean pressure (mPAP) ≥25 mm Hg ob- tained during right heart catheterisation at rest [16]1. A resting mPAP between